PD06-02 IMPORTANCE OF [-2] PROPSA MEASUREMENT IN A DIAGNOSIS OF PROSTATE CANCER: PROSTATE HEALTH INDEX TRIAL (PROPHET) - DIAGNOSTIC IMPACTS OF PROSTATE VOLUME-ADJUSTED INDICES ON GLEASON GRADE GROUP ≥2 OR ≥3 CANCER
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.